Promega Launches Wizard® HMW DNA Extraction Kit Ahead of 2020

Promega Corporation, a global biotechnology manufacturer, today launched its new Wizard® HMW DNA Extraction Kit for researchers working with large fragments of genomic DNA. The kit, as demonstrated in a poster presented at this week’s 2020 Advances in Genome Biology and Technology (AGBT) meeting, enables researchers to obtain DNA that will provide strong performance in long-read sequencing applications in a 90-minute manual protocol.

“We’ve worked with a lot of our customers and collaborators to develop a workflow where we’re able to get read lengths of 500kb in some of these new sequencing technologies, and it’s really enabled some of their research,” says Promega Research & Development Scientist Douglas Horejsh. “If you’re looking at an organism that’s never been sequenced or dealing with structural variations and rearrangements within the genome, it’s very difficult to take short reads to come up with a large sequence. A lot of workflows out there have been designed to purify smaller nucleic acids, but the Kit is able to get us up to 300kb and higher.”

Compared to leading competitors, the Wizard® HMW DNA Extraction Kit purifies a significantly higher proportion of fragments over 125kb. In long-read sequencing, the DNA from the Promega kit produced very long maximum reads and high N50 values, which indicates a higher proportion of large fragments in the sample.

The kit supports purification from a variety sample type including whole blood, bacterial cultures, cultured mammalian cells, and plant leaf tissue. It joins an existing portfolio of both manual and automated kits to extract a variety of nucleic acids from a broad range of sample types.

The kit is not for diagnostic use.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”